semaglutide causes cancer Does GLP-1 Cause Colon Cancer? Evidence and FDA Data Is Semaglutide Linked to Cancer?

Randomisation of patients was done to once-daily semaglutide, liraglutide, or placebo as 2:2:1 in one of four volume-matched doses (Both semaglutide 0.05, 0.1, 0.2, or 0.3 mg and liraglutide 0.3, 0.6, 1.2, or 1.8 mg, within each volume-matched dose group were compared)

In the SURMOUNT trials for tirzepatide, researchers used an escalation starting at 2.5 mg weekly, increasing by 2.5 mg every four weeks until reaching the target maintenance dose (typically 5 mg, 10 mg, or 15 mg)

These rare side effects include an increased heart rate, low blood sugar, gallbladder issues, and pancreatitis

Medical guidelines universally recommend the established once-weekly regimen

By week ten, the nausea was basically gone

Nonetheless, the dose is typically not more than 2 mg once a week